Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1967 2
1968 1
1970 5
1971 2
1972 7
1973 6
1974 2
1975 1
1976 2
1977 2
1978 1
1979 2
1980 3
1981 2
1982 5
1983 3
1984 4
1985 4
1986 5
1987 1
1988 9
1989 2
1990 3
1991 4
1992 2
1993 3
1994 6
1995 3
1996 7
1997 2
1998 1
1999 2
2000 6
2001 6
2002 2
2003 12
2004 8
2005 4
2006 3
2007 4
2008 1
2009 4
2010 4
2011 11
2012 14
2013 1
2014 3
2015 6
2017 5
2018 2
2019 2
2020 2
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Results by year

Filters applied: . Clear all
Page 1
Studies of HLA-B27-associated disease.
Taurog JD, Durand JP, el-Zaatari FA, Hammer RE. Taurog JD, et al. Among authors: durand jp. Am J Med. 1988 Dec 23;85(6A):59-60. doi: 10.1016/0002-9343(88)90388-9. Am J Med. 1988. PMID: 2904764 Review.
Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.
Arrondeau J, Huillard O, Tlemsani C, Cessot A, Boudou-Rouquette P, Blanchet B, Thomas-Schoemann A, Vidal M, Tigaud JM, Durand JP, Alexandre J, Goldwasser F. Arrondeau J, et al. Among authors: durand jp. Expert Opin Investig Drugs. 2015 May;24(5):673-87. doi: 10.1517/13543784.2015.1005736. Epub 2015 Jan 20. Expert Opin Investig Drugs. 2015. PMID: 25599887 Review.
Effect of glucuronidation on transport and tissue accumulation of tyrosine kinase inhibitors: consequences for the clinical management of sorafenib and regorafenib.
Tlemsani C, Huillard O, Arrondeau J, Boudou-Rouquette P, Cessot A, Blanchet B, Thomas-Schoemann A, Coriat R, Durand JP, Giroux J, Alexandre J, Goldwasser F. Tlemsani C, et al. Among authors: durand jp. Expert Opin Drug Metab Toxicol. 2015 May;11(5):785-94. doi: 10.1517/17425255.2015.1030392. Epub 2015 Mar 25. Expert Opin Drug Metab Toxicol. 2015. PMID: 25809423 Review.
Drug safety evaluation of sorafenib for treatment of solid tumors: consequences for the risk assessment and management of cancer patients.
Huillard O, Boissier E, Blanchet B, Thomas-Schoemann A, Cessot A, Boudou-Rouquette P, Durand JP, Coriat R, Giroux J, Alexandre J, Vidal M, Goldwasser F. Huillard O, et al. Among authors: durand jp. Expert Opin Drug Saf. 2014 May;13(5):663-73. doi: 10.1517/14740338.2014.907270. Epub 2014 Apr 3. Expert Opin Drug Saf. 2014. PMID: 24693873 Review.
Rift Valley fever in Chad.
Ringot D, Durand JP, Toulou H, Boutin JP, Davoust B. Ringot D, et al. Among authors: durand jp. Emerg Infect Dis. 2004 May;10(5):945-7. doi: 10.3201/eid1005.030621. Emerg Infect Dis. 2004. PMID: 15200839 Free PMC article.
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab.
Noel J, Jouinot A, Alexandre J, Ulmann G, Bretagne M, Castel-Ajgal Z, De Percin S, Vaquin-Villeminey C, Revel MP, Peyromaure M, Boudou-Rouquette P, Arrondeau J, Gataa I, Durand JP, Goldwasser F, Huillard O. Noel J, et al. Among authors: durand jp. Cancers (Basel). 2022 Jun 30;14(13):3214. doi: 10.3390/cancers14133214. Cancers (Basel). 2022. PMID: 35804986 Free PMC article.
[Oxygen requirements of the myocardium].
Delaye J, Mpetshi I, Durand JP. Delaye J, et al. Among authors: durand jp. Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:7-12. Arch Mal Coeur Vaiss. 1983. PMID: 6305299 Review. French.
199 results